(BPCA) Information HDAC11 Synonyms Coordinating Center was funded under contract HHSN275201700002C (PI
(BPCA) Information Coordinating Center was funded beneath contract HHSN275201700002C (PI, Ravinder Anand). Y.S.S.W. was RGS16 Purity & Documentation supported through a University of North Carolina (UNC)/Nuventra Pharmacokinetics/Pharmacodynamics Fellowship. M.C.-W. received assistance for analysis from the National Institutes of Overall health (grants 1R01-HD076676-01A1 and 1K24-AI143971),July 2021 Volume 65 Concern 7 e02149-20 aac.asmWu et al.Antimicrobial Agents and Chemotherapythe National Institute of Allergy and Infectious Diseases (grants HHSN272201500006I and HHSN272201300017I), the National Institute of Kid Well being and Human Improvement (NICHD) (grant HHSN275201000003I), the U.S. Meals and Drug Administration (grant 5U18FD006298), and sector for drug improvement in adults and young children. C.P.H. received salary support for investigation from NICHD (grants 1K23HD090239 and R13HD102136), the National Heart Lung and Blood Institute (NHLBI) (grant R61/R33HL147833), plus the U.S. Meals and Drug Administration (grants 1R01-FD006099 [PI, Matthew Laughon] and 5U18-FD006298 [PI, Daniel K. Benjamin, Jr.]), and from the U.S. government for his work in pediatric clinical pharmacology (contract HHSN275201800003I [PI, Daniel K. Benjamin, Jr.] below the best Pharmaceuticals for Kids Act), from the nonprofit Burroughs Wellcome Fund, and from other sponsors for drug development in adults and kids (dcri/about-us/ conflict-of-interest/). J.G.G. received investigation support in the National Institute of General Healthcare Sciences (NIGMS)-funded T32 system (award 5T32GM122741), at the same time as the American Foundation for Pharmaceutical Education (AFPE). D.G. received study support from the NICHD (grants K23HD083465 and R01HD096435). The content material is solely the duty in the authors and does not necessarily represent the official views from the National Institutes of Well being. Y.S.S.W. and D.G. wrote the manuscript; Y.S.S.W. and D.G. designed the study; Y.S.S.W., M.C.-W., C.P.H., J.G.G., J.A., M.C., and D.G. performed the investigation; Y.S.S.W. and J.G.G. analyzed the information. PTN Steering Committee Members include Daniel K. Benjamin, Jr., Christoph Hornik, Kanecia Zimmerman, Phyllis Kennel, and Rose Beci, Duke Clinical Analysis Institute, Durham, NC; Chi Dang Hornik, Duke University Health-related Center, Durham, NC; Gregory L. Kearns, Texas Christian University and UNTHSC College of Medicine, Fort Worth, TX; Matthew Laughon, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ian M. Paul, Penn State College of Medicine, Hershey, PA; Janice Sullivan, University of Louisville, Louisville, KY; Kelly Wade, Children’s Hospital of Philadelphia, Philadelphia, PA; and Paula Delmore, Wichita Medical Research and Education Foundation, Wichita, KS. The Eunice Kennedy Shriver National Institute of Child Health and Human Improvement (NICHD) group members include things like Perdita Taylor-Zapata and June Lee. The Emmes Organization, LLC (Data Coordinating Center), team members incorporate Ravinder Anand, Gaurav Sharma, Gina Simone, Kim Kaneshige, and Lawrence Taylor. The PTN Publications Committee is chaired by Thomas Green, Ann Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL. The Pediatric Trials Network trimethoprim-sulfamethoxazole POPS study team, principal investigators (PIs), and study coordinators (SCs) are as follows: at the Duke Clinical Study Institute, Tammy Day (clinical study associate [CRA]); at the Universitde Montr l, Julie Autmizguine (PI); at the University of North Carolina at Chapel Hill, Matthew.
